Canine mast cell tumours part I: Clinical and survival outcomes.
Vanessa S TamlinCynthia D K BottemaLucy WoolfordElizabeth C DobsonAllan E KessellAnne E PeastonPublished in: Veterinary medicine and science (2022)
In this sample of dogs, tumour histological grading remained the single most powerful prognostic indicator for MCT outcome. However, concurrent evaluation of multiple prognostically significant parameters provides information of potential value to inform therapeutic management for each patient.